Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy

ClinicalTrials.gov ID: NCT01437566

Public ClinicalTrials.gov record NCT01437566. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Double-Blind, Placebo Controlled, Randomized Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor Therapy

Study identification

NCT ID
NCT01437566
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
318 participants

Conditions and interventions

Conditions

Interventions

  • Fulvestrant Drug
  • GDC-0941 Drug
  • GDC-0941 Matching Placebo Drug
  • GDC-0980 Drug
  • GDC-0980 Matching Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2011
Primary completion
Mar 31, 2016
Completion
Mar 31, 2016
Last update posted
Nov 1, 2016

2011 – 2016

United States locations

U.S. sites
41
U.S. states
16
U.S. cities
38
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Hayward California 94545
Not listed Oakland California 94611
Not listed Roseville California 95661
Not listed Sacramento California 95825
Not listed San Francisco California 94115
Not listed San Jose California 95119
Not listed Santa Clara California 95051
Not listed South San Francisco California 94080
Not listed Vallejo California 94589
Not listed Walnut Creek California 94596
Not listed Washington D.C. District of Columbia 20010
Not listed Boca Raton Florida 33428
Not listed Fort Myers Florida 33916
Not listed Jacksonville Florida 32224
Not listed St. Petersburg Florida 33705
Not listed Marietta Georgia 30060
Not listed Joliet Illinois 60435
Not listed Peoria Illinois 61615
Not listed Wichita Kansas 67214-3728
Not listed Boston Massachusetts 02115
Not listed Boston Massachusetts 02215
Not listed St Louis Missouri 63128
Not listed Basking Ridge New Jersey 07920
Not listed Hackensack New Jersey 07601
Not listed Commack New York 11725
Not listed New York New York 10065
Not listed Rockville Centre New York 11570
Not listed Sleepy Hollow New York 10591
Not listed Philadelphia Pennsylvania 19104
Not listed Charleston South Carolina 29425
Not listed Chattanooga Tennessee 37404
Not listed Germantown Tennessee 38138
Not listed Nashville Tennessee 37211
Not listed Nashville Tennessee 37232
Not listed Dallas Texas 75246
Not listed Fort Worth Texas 76104
Not listed Houston Texas 77030-4095
Not listed Houston Texas 77030
Not listed Tyler Texas 75702
Not listed Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01437566, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2016 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01437566 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →